ElectroCore Inc
Company Overview
electroCore, Inc. is a commercial-stage bioelectronic medicine company that develops and commercializes non-invasive vagus nerve stimulation (nVNS) therapies. Their primary product is gammaCore, a hand-held medical device for the treatment of various conditions through electrical stimulation of the vagus nerve. The device is primarily used for the prevention and treatment of migraine and cluster headaches.
The company focuses on developing and commercializing their proprietary nVNS technology platform to treat multiple conditions in neurology, rheumatology, and other fields. Their business model is based on selling medical devices and related consumables, which represents legitimate exchange of goods and services.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $6.55m | $9.21m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $6.14m | $8.73m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $5.44m | $9.29m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate ElectroCore Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.